Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth & Waleed M Hussein. (2022) Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances. International Journal of Nanomedicine 17, pages 869-900.
Read now
Read now
Feifei Duan, Jiaqi Chen, Hao Yao, Yuting Wang, Yanyan Jia, Zhiting Ling, Youwei Feng, Zhiming Pan, Yuelan Yin & Xin’An Jiao. (2021) Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7. Human Vaccines & Immunotherapeutics 17:6, pages 1568-1577.
Read now
Read now
Sijin Li, Qishu Zhang, Hongmei Bai, Weiwei Huang, Congyan Shu, Chao Ye, Wenjia Sun & Yanbing Ma. (2019) Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor. International Journal of Nanomedicine 14, pages 8209-8219.
Read now
Read now
Jin Qiu, Shiwen Peng, Andrew Yang, Ying Ma, Liping Han, Max A. Cheng, Emily Farmer, Chien-Fu Hung & T.-C. Wu. (2018) Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrins-mediated CD8+ T cell infiltration to control mucosal tumor growth. OncoImmunology 7:8.
Read now
Read now
Gaurav Gupta, Reinhard Glueck & Pankaj R. Patel. (2017) HPV vaccines: Global perspectives. Human Vaccines & Immunotherapeutics 13:6, pages 1421-1424.
Read now
Read now
Articles from other publishers (75)
Xiaodan Huang, Lanqing Huo, Beibei Xiao, Yi Ouyang, Foping Chen, Junyun Li, Xueping Zheng, Denghui Wei, Yuanzhong Wu, Ruhua Zhang, Xinping Cao, Tiebang Kang & Ying Gao. (2023) Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer. Cell Death & Differentiation.
Crossref
Crossref
Sarojamma Vemula, Sabeerabi Bonala, Neha Krishna Vadde, Jay Z. Natu, Raasil Basha, Ramakrishna Vadde & Sarfraz Ahmad. (2023) Drug resistance and immunotherapy in gynecologic cancers. Life Sciences 332, pages 122104.
Crossref
Crossref
Agrima Yadav, Shikha Yadav & Md. Aftab Alam. (2023) Immunotherapies landscape and associated inhibitors for the treatment of cervical cancer. Medical Oncology 40:11.
Crossref
Crossref
Sahar Sadr-Momtaz, Maryam Aftabi, Emad Behboudi, Malihe Naderi, Anahita Hashemzadeh-Omran & Abdolvahab Moradi. (2023) NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice. BMC Research Notes 16:1.
Crossref
Crossref
Lydia Riepler, Laura-Sophie Frommelt, Sarah Wilmschen-Tober, Wilbert Mbuya, Kathrin Held, André Volland, Dorothee von Laer, Christof Geldmacher & Janine Kimpel. (2023) Therapeutic Efficacy of a VSV-GP-based Human Papilloma Virus Vaccine in a Murine Cancer Model. Journal of Molecular Biology 435:13, pages 168096.
Crossref
Crossref
Anna C. Jones, Karah H. Brown, Tianyun Guan, Luke A. Smith, Cole R. Formslag, Emerson D. Farjado, Qian Bai, Harrison D. Luechtefeld, Mark R. Wakefield, Lijun Dong & Yujiang Fang. (2023) The past, present, and future of immunotherapy for endometrial adenocarcinoma. Medical Oncology 40:7.
Crossref
Crossref
Yuchong Yu, Yao Liu, Yuhong Li, Xiaoming Yang, Mi Han & Qiong Fan. (2023) Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer. Cancer Cell International 23:1.
Crossref
Crossref
Mehran Mahooti, Elahe Abdolalipour, Seyed Mohammad Miri & Amir Ghaemi. 2023. Probiotics in Anticancer Immunity. Probiotics in Anticancer Immunity
211
235
.
Fuxing Chen, Lingzhi Shen, Ying Wang, Yaping Chen, Xuejiao Pan, Hui Liang & Hu Yu. (2023) Signatures of immune cell infiltration for predicting immune escape and immunotherapy in cervical cancer. Aging.
Crossref
Crossref
Yiqing Tang, Cuicui Qiao, Qianqian Li, Xiaodi Zhu, Ronglan Zhao & Xiaoxiang Peng. (2022) Research Progress in the Relationship Between P2X7R and Cervical Cancer. Reproductive Sciences 30:3, pages 823-834.
Crossref
Crossref
Rani S. Sellers & Keith Nelson. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
335
396
.
Masahiro Kagabu & Tsukasa Baba. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
19
.
Yiting Cai. (2022) Progress of research on human papilloma virus vaccine application. Highlights in Science, Engineering and Technology 19, pages 142-147.
Crossref
Crossref
Kousain Kousar, Tahir Ahmad, Faiza Naseer, Salik Kakar & Sadia Anjum. (2022) Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma. Cancers 14:18, pages 4458.
Crossref
Crossref
Rahul Bhattacharjee, Lamha Kumar, Archna Dhasmana, Tamoghni Mitra, Abhijit Dey, Sumira Malik, Bonglee Kim & Rohit Gundamaraju. (2022) Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs. Frontiers in Oncology 12.
Crossref
Crossref
Vidhu B. Joshi, Philippe E. Spiess, Andrea Necchi, Curtis A. Pettaway & Jad Chahoud. (2022) Immune-based therapies in penile cancer. Nature Reviews Urology 19:8, pages 457-474.
Crossref
Crossref
Lydia Patrick, Sabrina Bakeera-Kitaka, Joseph Rujumba & Oliver Ombeva Malande. (2022) Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda. PLOS ONE 17:6, pages e0269655.
Crossref
Crossref
Rahul Bhattacharjee, Sabya Sachi Das, Smruti Sudha Biswal, Arijit Nath, Debangshi Das, Asmita Basu, Sumira Malik, Lamha Kumar, Sulagna Kar, Sandeep Kumar Singh, Vijay Jagdish Upadhye, Danish Iqbal, Suliman Almojam, Shubhadeep Roychoudhury, Shreesh Ojha, Janne Ruokolainen, Niraj Kumar Jha & Kavindra Kumar Kesari. (2022) Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Critical Reviews in Oncology/Hematology 174, pages 103675.
Crossref
Crossref
Niloofar Khairkhah, Azam Bolhassani & Reza Najafipour. (2022) Current and future direction in treatment of HPV-related cervical disease. Journal of Molecular Medicine 100:6, pages 829-845.
Crossref
Crossref
Hannah R. Turbeville, Tiffany A. Toni & Clint Allen. (2022) Immune Landscape and Role of Immunotherapy in Treatment of HPV-Associated Head and Neck Squamous Cell Carcinoma (HNSCC). Current Otorhinolaryngology Reports 10:1, pages 96-107.
Crossref
Crossref
Seyed Amirreza Fatemi, Nadia Seifi, Shiva Rasekh, Sogand Amiri, Seyed Mohammad Iman Moezzi, Ashkan Bagheri, Shirin Fathi & Manica Negahdaripour. 2022. Immunotherapeutics. Immunotherapeutics
51
90
.
Ssu-Hsueh Tseng, Li Liu, Shiwen Peng, Jinhwi Kim, Louise Ferrall, Chien-Fu Hung & T. -C. Wu. (2021) Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine. Journal of Biomedical Science 28:1.
Crossref
Crossref
Momeneh Ghanaat, Nasser Hashemi Goradel, Arash Arashkia, Nasim Ebrahimi, Sajjad Ghorghanlu, Ziba Veisi Malekshahi, Esmail Fattahi, Babak Negahdari & Hami Kaboosi. (2021) Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer. Acta Pharmacologica Sinica 42:12, pages 1981-1990.
Crossref
Crossref
Matin Kayyal, Azam Bolhassani, Zahra Noormohammadi & Majid Sadeghizadeh. (2021) In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses. Molecular Biotechnology 63:12, pages 1192-1222.
Crossref
Crossref
Simon Beyaert, Jean-Pascal Machiels & Sandra Schmitz. (2021) Vaccine-Based Immunotherapy for Head and Neck Cancers. Cancers 13:23, pages 6041.
Crossref
Crossref
Maria Lobato Gómez, Xin Huang, Derry Alvarez, Wenshu He, Can Baysal, Changfu Zhu, Victoria Armario‐Najera, Amaya Blanco Perera, Pedro Cerda Bennasser, Andera Saba‐Mayoral, Guillermo Sobrino‐Mengual, Ashwin Vargheese, Rita Abranches, Isabel Alexandra Abreu, Shanmugaraj Balamurugan, Ralph Bock, Johannes.F. Buyel, Nicolau B. da Cunha, Henry Daniell, Roland Faller, André Folgado, Iyappan Gowtham, Suvi T. Häkkinen, Shashi Kumar, Sathish Kumar Ramalingam, Cristiano Lacorte, George P. Lomonossoff, Ines M. Luís, Julian K.‐C. Ma, Karen. A. McDonald, Andre Murad, Somen Nandi, Barry O’Keefe, Kirsi‐Marja Oksman‐Caldentey, Subramanian Parthiban, Mathew J. Paul, Daniel Ponndorf, Elibio Rech, Julio C. M. Rodrigues, Stephanie Ruf, Stefan Schillberg, Jennifer Schwestka, Priya S. Shah, Rahul Singh, Eva Stoger, Richard M. Twyman, Inchakalody P. Varghese, Giovanni R. Vianna, Gina Webster, Ruud H. P. Wilbers, Teresa Capell & Paul Christou. (2021) Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases. Plant Biotechnology Journal 19:10, pages 1901-1920.
Crossref
Crossref
Maxwell Y. Lee & Clint T. Allen. (2021) Immunotherapy for HPV Malignancies. Seminars in Radiation Oncology 31:4, pages 361-370.
Crossref
Crossref
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, Chien-Fu Hung & T.-C. Wu. (2021) Cervical Cancer Immunotherapy: Facts and Hopes. Clinical Cancer Research 27:18, pages 4953-4973.
Crossref
Crossref
Amber L. Watters, Heidi J. Hansen, Ashish A. Patel & Joel Epstein. 2021. Burket's Oral Medicine. Burket's Oral Medicine
211
257
.
Han Dai, Jie Han & Eric Lichtfouse. (2021) Smarter cures to combat COVID-19 and future pathogens: a review. Environmental Chemistry Letters 19:4, pages 2759-2771.
Crossref
Crossref
Lin Su, Yunwen Zhang, Xiang Zhang, Ting Liu, Sijing Liu, Yongyu Li, Mingjuan Jiang, Tian Tang, Haiqian Shen & Chuan Wang. (2021) Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model. Scientific Reports 11:1.
Crossref
Crossref
Zhilin Song, Yanru Cui, Qiufu Li, Junhang Deng, Xianping Ding, Jiaoyu He, Yiran Liu, Zhuang Ju & Liyuan Fang. (2021) The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China. Virology Journal 18:1.
Crossref
Crossref
Samuel T. Pellom, Claire Smalley Rumfield, Y. Maurice MorillonIIII, Nicholas Roller, Lisa K. Poppe, Douglas E. Brough, Helen Sabzevari, Jeffrey Schlom & Caroline Jochems. (2021) Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009. JCI Insight 6:7.
Crossref
Crossref
Fadi Abboodi, Nella C. Delva, Jennifer Emmel, Ariana Renrick, Phillip Buckhaults, Carolyn E. Banister, Kim E. Creek & Lucia Pirisi. (2021) Human papillomavirus-mediated carcinogenesis and tumor progression. Genome Instability & Disease 2:2, pages 71-91.
Crossref
Crossref
Janin Chandra, Siok Min Teoh, Paula Kuo, Lynn Tolley, Abate Assefa Bashaw, Zewen Kelvin Tuong, Yang Liu, Zibin Chen, James W. Wells, Chengzhong Yu, Ian H. Frazer & Meihua Yu. (2021) Manganese-Doped Silica-Based Nanoparticles Promote the Efficacy of Antigen-Specific Immunotherapy. The Journal of Immunology 206:5, pages 987-998.
Crossref
Crossref
Zhen Dong, Renjian Hu, Yan Du, Li Tan, Lin Li, Juan Du, Longchang Bai, Yingkang Ma & Hongjuan Cui. (2021) Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers. Frontiers in Immunology 11.
Crossref
Crossref
Carl Christofer Juhlin, Henrik Falhammar, Magnus Kjellman, Jan Åhlén, Staffan Welin & Jan Calissendorff. (2020) Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission. BMC Gastroenterology 20:1.
Crossref
Crossref
Rosella Franconi, Silvia Massa, Francesca Paolini, Patrizia Vici & Aldo Venuti. (2020) Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers. Cancers 12:11, pages 3101.
Crossref
Crossref
R. K. Salyaev, N. I. Rekoslavskaya & A. S. Stolbikov. (2021) New Data on the Influence of the HPV16 E2 Early Protein Obtained in Plant Expression Nanosystems on Tumor Tissues of Female Mice Induced by Injection of HeLa Cancer Cells in Hip Muscle. Nanotechnologies in Russia 15:7-8, pages 516-522.
Crossref
Crossref
Tae Heung Kang, Jung Hwa Park, Andrew Yang, Hyun Jin Park, Sung Eun Lee, Young Seob Kim, Gun-Young Jang, Emily Farmer, Brandon Lam, Yeong-Min Park & Chien-Fu Hung. (2020) Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment. Nature Communications 11:1.
Crossref
Crossref
Alexander C. Cohen, Brandon M. Roane & Charles A. LeathIIIIII. (2020) Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy. Drugs 80:3, pages 217-227.
Crossref
Crossref
Asmita Pal & Rita Kundu. (2020) Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Frontiers in Microbiology 10.
Crossref
Crossref
R Ivancic, H Iqbal, B deSilva, Q Pan & L Matrka. (2020) Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis. Clinical and Experimental Immunology 199:2, pages 131-142.
Crossref
Crossref
Svetlane Dimi, David Zucman, Olivier Chassany, Christophe Lalanne, Thierry Prazuck, Emmanuel Mortier, Catherine Majerholc, Isabelle Aubin-Auger, Pierre Verger & Martin Duracinsky. (2019) Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?. BMC Infectious Diseases 19:1.
Crossref
Crossref
Rouhollah Vahabpour, Parya Basimi, Farzin Roohvand, Hassan Asadi, Gholnaz M. Irani, Rezvan Zabihollahi & Azam Bolhassani. (2019) Anti-viral Effects of Superpositively Charged Mutant of Green Fluorescent Protein. Protein & Peptide Letters 26:12, pages 930-939.
Crossref
Crossref
Laura Martin-Gomez, Anna R. Giuliano, William J. Fulp, Jimmy Caudell, Michelle Echevarria, Bradley Sirak, Martha Abrahamsen, Kimberly A. Isaacs-Soriano, Juan C. Hernandez-Prera, Bruce M. Wenig, Kathryn Vorwald, Caitlin P. McMullen, J. Trad Wadsworth, Robbert J. Slebos & Christine H. Chung. (2019) Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery 145:5, pages 460.
Crossref
Crossref
Jun-Hui Yu, Wei-Wu Shi, Mei-Ying Zhou, Jia-Mei Liu, Qiu-Yue Han & Hui-Hui Xu. (2019) Genetic variability and oncogenic risk association of human papillomavirus type 58 E6 and E7 genes in Taizhou area, China. Gene 686, pages 171-176.
Crossref
Crossref
Paola Di Bonito, Luisa Accardi, Luisa Galati, Flavia Ferrantelli & Maurizio Federico. (2019) Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes. Cancers 11:2, pages 138.
Crossref
Crossref
Chiara Di Tucci, Carmela Capone, Giulia Galati, Valentina Iacobelli, Michele C Schiavi, Violante Di Donato, Ludovico Muzii & Pierluigi Benedetti Panici. (2019) Immunotherapy in endometrial cancer: new scenarios on the horizon. Journal of Gynecologic Oncology 30:3.
Crossref
Crossref
Maike Schmidt & Jennie R. Lill. (2019) MHC class I presented antigens from malignancies: A perspective on analytical characterization & immunogenicity. Journal of Proteomics 191, pages 48-57.
Crossref
Crossref
Boris Schlenker & Peter Schneede. (2019) The Role of Human Papilloma Virus in Penile Cancer Prevention and New Therapeutic Agents. European Urology Focus 5:1, pages 42-45.
Crossref
Crossref
Mario Preti, Gianluigi Radici & Leonardo Micheletti. 2019. Vulvar Disease. Vulvar Disease
385
391
.
Basit Jabbar, Shazia Rafique, Outi M. H. Salo-Ahen, Amjad Ali, Mobeen Munir, Muhammad Idrees, Muhammad Usman Mirza, Michiel Vanmeert, Syed Zawar Shah, Iqra Jabbar & Muhammad Adeel Rana. (2018) Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis. Frontiers in Immunology 9.
Crossref
Crossref
Miaomiao Ma, Yaning Feng, Peiwen Fan, Xuan Yao, Yanchun Peng, Tao Dong & Ruozheng Wang. (2018) Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma. Infectious Agents and Cancer 13:1.
Crossref
Crossref
Juemin Xi, Junying Chen, Miaoling Xu, Hongying Yang, Songjiao Wen, Yue Pan, Xiaodan Wang, Chao Ye, Lijuan Qiu & Qiangming Sun. (2018) The polymorphisms of LCR, E6, and E7 of HPV-58 isolates in Yunnan, Southwest China. Virology Journal 15:1.
Crossref
Crossref
Jin Qiu, Shiwen Peng, Ying Ma, Andrew Yang, Emily Farmer, Max A. Cheng, Richard B.S. Roden, T.-C. Wu, Yung-Nien Chang & Chien-Fu Hung. (2018) Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination. Virology 525, pages 205-215.
Crossref
Crossref
Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, Minakshi Prasad, Rekha Khandia, Sameer Hassan, Ashok Munjal, Ruchi Tiwari, Kumaragurubaran Karthik, Deepak Kumar, Hafiz M. N. Iqbal & Wanpen Chaicumpa. (2018) Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus. Frontiers in Immunology 9.
Crossref
Crossref
Max A. ChengEmily FarmerClaire HuangJohn LinChien-Fu HungT.-C. Wu. (2018) Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases. Human Gene Therapy 29:9, pages 971-996.
Crossref
Crossref
Chiara Di Tucci, Michele Carlo Schiavi, Pierangelo Faiano, Ottavia D’Oria, Giovanni Prata, Valentina Sciuga, Andrea Giannini, Innocenza Palaia, Ludovico Muzii & Pierluigi Benedetti Panici. (2018) Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers. Critical Reviews in Oncology/Hematology 128, pages 30-42.
Crossref
Crossref
Yong‑Xia Wang, Zhe‑Ying Zhang, Jian‑Qiang Wang, Xin‑Lai Qian & Jing Cui. (2018) HPV16 E7 increases COX‑2 expression and promotes the proliferation of breast cancer. Oncology Letters.
Crossref
Crossref
P. Schneede & B. Schlenker. (2018) Humane Papillomaviren und PeniskarzinomHuman papillomavirus and penile cancer. Der Urologe 57:4, pages 413-417.
Crossref
Crossref
Fatemeh Motevalli, Azam Bolhassani, Shilan Hesami & Sepideh Shahbazi. (2018) Supercharged green fluorescent protein delivers HPV16E7 DNA and protein into mammalian cells in vitro and in vivo. Immunology Letters 194, pages 29-39.
Crossref
Crossref
Matthew M. Symer & Heather L. Yeo. (2018) Recent advances in the management of anal cancer. F1000Research 7, pages 1572.
Crossref
Crossref
Andrew Yang, Shiwen Peng, Emily Farmer, Qi Zeng, Max A. Cheng, Xiaowu Pang, T. -C. Wu & Chien-Fu Hung. (2017) Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus. Cell & Bioscience 7:1.
Crossref
Crossref
Joongho Joh, Paula M. Chilton, Sarah A. Wilcher, Maryam Zahin, Jino Park, Mary L. Proctor, Shin-je Ghim & Alfred B. Jenson. (2017) T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1. Experimental and Molecular Pathology 103:2, pages 181-190.
Crossref
Crossref
Jennifer S. Smith, Busola Sanusi, Avril Swarts, Mark Faesen, Simon Levin, Bridgette Goeieman, Sibongile Ramotshela, Ntombiyenkosi Rakhombe, Anna L. Williamson, Pam Michelow, Tanvier Omar, Michael G. Hudgens & Cynthia Firnhaber. (2017) A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. American Journal of Obstetrics and Gynecology 217:2, pages 183.e1-183.e11.
Crossref
Crossref
Y Sun, S Peng, A Yang, E Farmer, T-C Wu & C-F Hung. (2017) Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation. Gene Therapy 24:7, pages 408-415.
Crossref
Crossref
Ying Ma, Andrew Yang, Shiwen Peng, Jin Qiu, Emily Farmer, Chien-Fu Hung & T.-C. Wu. (2017) Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model. Vaccine 35:31, pages 3850-3858.
Crossref
Crossref
Ying Liu, Yaqi Pan, Weijiao Gao, Yang Ke & Zheming Lu. (2017) Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women. Scientific Reports 7:1.
Crossref
Crossref
Adila Aipire, Jinyu Li, Pengfei Yuan, Jiang He, Yelang Hu, Lu Liu, Xiaoli Feng, Yijie Li, Fuchun Zhang, Jianhua Yang & Jinyao Li. (2017) Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine. Scientific Reports 7:1.
Crossref
Crossref
Andrew Yang, Emily Farmer, John Lin, T.-C. Wu & Chien-Fu Hung. (2017) The current state of therapeutic and T cell-based vaccines against human papillomaviruses. Virus Research 231, pages 148-165.
Crossref
Crossref
Karin Hellner & Lucy Dorrell. (2017) Recent advances in understanding and preventing human papillomavirus-related disease. F1000Research 6, pages 269.
Crossref
Crossref
Y. X. Wang, Y. Z. Li, Z. Y. Zhang, J. Q. Wang, J. Cui & X. L. Qian. (2017) HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression. BioMed Research International 2017, pages 1-12.
Crossref
Crossref
Andrew Yang, Emily Farmer, T. C. Wu & Chien-Fu Hung. (2016) Perspectives for therapeutic HPV vaccine development. Journal of Biomedical Science 23:1.
Crossref
Crossref
Su-I Lin, Ming-Hsi Huang, Yu-Wen Chang, I-Hua Chen, Steve Roffler, Bing-Mae Chen, Yuh-Pyng Sher & Shih-Jen Liu. (2016) Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice. Cancer Letters 377:2, pages 126-133.
Crossref
Crossref